Research Article
Pediatric COVID-19: Correlations between Clinical and Imaging Perspectives
Table 1
Demographics and clinical characteristics among the studied COVID-19 patients.
| | Variables () |
| | Age in years, median (IQR) | 6 (2–10) | | Range | 2 months–15years | | Males (%) | 44 (55.0%) | | Onset of the disease | | | Before hospital admission | 60 (75%) | | Hospital acquired | 20 (25%) | | Duration of the disease (days), | | | Range | 4–30 | | Fatigue | 75 (93.8%) | | Fever (%) | 73 (91.3%) | | Respiratory manifestations | 72 (90%) | | Upper respiratory tract symptoms | 72 (90%) | | Lower respiratory tract symptoms | 47 (58.8%) | | Wheezes | 50 (62.5%) | | Dyspnea | 47 (58.8%) | | Sore throat | 26 (32.5%) | | Rhinorrhea | 8 (10.0%) | | Anosmia | 1 (1.3%) | | Oxygen saturation | | | Skin manifestations (%) | 35 (43.8%) | | Cardiac manifestations (%) | 28 (35.0%) | | Myalgia and bony aches | 25 (31.3%) | | Headache and irritability | 16 (20.0%) | | Neurological manifestations (%) | 14 (17.5%) | | Complicated COVID-19 (%) | 59 (73.75%) | | Pneumonia | 23 (39%) | | Pleural effusion | 7 (11.8) | | MIS-C | 18 (30.5%) | | Septic shock | 9 (15.3%) | | Encephalitis | 2 (3.4%) | | Comorbid conditions (%) | 40 (50%) | | Immunological diseases | 12 (30%) | | Surgical problems | 7 (17.5%) | | Chronic respiratory diseases | 4 (10.0%) | | Malignancy | 4 (10.0%) | | Chronic renal diseases | 4 (10.0%) | | Neurological disorders | 3 (7.5%) | | Hematological diseases | 2 (5.0%) | | Diabetic ketoacidosis | 2 (5.0%) | | Biliary atresia | 1 (2.5%) | | Chromosomal disorders | 1 (2.5%) |
|
|
MIS-C: Multisystem inflammatory syndrome in children.
|
